ExploreWatchlistsPricing
  1. JP-listed companies
  2. TORII PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Marketable securities, non-current

TORII PHARMACEUTICAL CO., LTD. (E00934)

Market cap
P/E ratio
Torii Pharmaceutical manufactures and sells prescription medicines for kidney disease, skin conditions, allergies, and other medical needs in Japan.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndMarketable securities, non-current (Million JPY)YoY (%)
Dec 31, 202433,197-2.28%
Dec 31, 202333,970+12.18%
Dec 31, 202230,282+35.74%
Dec 31, 202122,309+7.20%
Dec 31, 202020,810+5.29%
Dec 31, 201919,764+43.53%
Dec 31, 201813,770+84.14%
Dec 31, 20177,478+92.88%
Dec 31, 20163,877-42.99%
Dec 31, 20156,800-3.82%
Dec 31, 20147,070

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat